Moneycontrol PRO
LAMF
LAMF

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Cipla jumps 6% after management's FY18 outlook; analysts retain hold rating

  • Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey

  • Expect to see 18-20% growth for FY18: TCI Express

  • Cipla Q4: Net profit seen at Rs 346.8 crore, revenues could rise to Rs 3,790 crore: Poll

  • Cipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

  • Cipla Q3 profit seen up 5%; US, India & EMs may lift revenue 20%

  • Good Q3 but Dr Reddy's still far from sustainable growth: Expert

  • Cipla Q3 PAT seen up 8.2% to Rs 383.4 cr: ICICI Securities

  • Cipla Q3 PAT may dip 2.6% to Rs 345 cr: KR Choksey

  • Cipla Q2 profit seen down 13%, lower Nexium sales may hit margin

  • Cipla Q2 PAT seen up 11.2% to Rs 406 cr: Centrum

  • Cipla Q1 profit seen down 41% to Rs 385 cr, revenue may be flat

  • Cipla Q1 PAT seen up by 315% at Rs 335.9 cr: Religare Research

  • Cipla Q1 PAT seen up 522.4% to Rs 503.3 cr: Edelweiss

  • Q1 earnings: Which sectors will do well, which won't?

  • Expect 10-15 launches in the US this year: Cipla

  • Cipla Q4 profit seen up 39%, likely to meet FY16 growth guidance

  • Hold Cipla; on track to meet 20%+ EBITDA margins in'16: Religare

  • Cipla Q3 net seen up 26%; forex may hit ex-US export markets

  • Lupin Q3: Prakash Diwan upbeat; Angle Broking neutral

  • Cipla Q2 profit seen up 74% on export formulation biz boost

  • Cipla Q1 profit seen up 47% on higher other income, revenue

  • Buy Dr Reddys at every dip; cautious on Cipla: IIFL

  • Sunshine stocks! Few positive surprises seen in weak Q1

  • Q1 earnings to be tepid; analysts pick best & worst sectors

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347